The process begins with the extraction of DNA from cancerous tissue. Specific regions of interest are then captured and enriched using methods such as polymerase chain reaction (PCR) or hybridization capture. These regions are subsequently sequenced using next-generation sequencing (NGS) technologies. Bioinformatics tools are then employed to analyze the data, identifying mutations and other genetic alterations.
